Methyl 4-hydroxypiperidine-2-carboxylate hydrochloride, 97%, 5g

5-[4-(ethylsulfonyl)phenyl]-1,3,4-oxadiazol-2-amine, 95.0%, 500mg

(S)-10-Benzyl-23-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-6,9,12,15,18-pentaoxo-3-oxa-5,8,11,14,17-pentaazatricosan-1-oic acid, 95%, 50mg

4-(Phenoxymethyl)benzoic acid, 95.0%, 1g

L-Azetidine-2-carboxylic Acid [Antagonist of L-Proline]>98.0%(T)1g

3-BROMO-4-(DIFLUOROMETHYL)ANISOLE, 95.0%, 10g

3-CHLORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 250mg

3,5-Dimethoxypicolinonitrile, 95.0%, 5g

4-amino-6-(2-thienyl)pyridazin-3(2{H})-one, 95.0%, 500mg

Methyl 2-amino-4-methoxybenzo[d]thiazole-6-carboxylate, 97%, 1g

6-(4-BROMOPHENYL)-4,5-DIHYDRO-3(2H)-PYRIDAZINONE, 97.0%, 25g

(2-Isopropoxy-4-(trifluoromethyl)phenyl)boronic acid, 95.0%, 5g

Molybdic acid, min. 85%, pa, ACS, 100 g, plastic packaging.